Matrix metalloproteinase 9 activity in urine of patients at risk for premature delivery.
A simple, noninvasive assay was used to quantitate urinary matrix metalloproteinase 9 activity among 15 patients with threatened premature labor. Both positive and negative predictive values for risk for premature delivery were 80%.
Agrez
M
M
Disciplines of Surgical Science, Faculty of Medicine, The University of Newcastle, Callaghan, New South Wales, Australia.
Gu
X
X
Giles
W
W
D000037:Abruptio Placentae / Q000150:complications / Q000201:enzymology; D001826:Body Fluids / Q000737:chemistry; D002584:Cervix Uteri / Q000378:metabolism; D017364:Collagenases / Q000652:urine*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000150:complications / Q000201:enzymology; D005353:Fibronectins / Q000032:analysis; D005865:Gestational Age; D006801:Humans; D020780:Matrix Metalloproteinase 9; D007752:Obstetric Labor, Premature / Q000201:enzymology*; D011247:Pregnancy; D012307:Risk Factors; D014621:Vagina / Q000378:metabolism
D005353:Fibronectins; D017364:Collagenases; D020780:Matrix Metalloproteinase 9